Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy

por Miura, Itaru, Horikoshi, Sho, Ichinose, Mizue, Suzuki, Yuhei, Watanabe, Kenya
Publicado 2023

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia

por Kaneko, Haruka, Miura, Itaru, Kanno-Nozaki, Keiko, Horikoshi, Sho, Hino, Mizuki, Yabe, Hirooki
Publicado 2018

Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report

por Ito, Masashi, Kunii, Yasuto, Horikoshi, Sho, Miura, Itaru, Itagaki, Shuntaro, Shiga, Tetsuya, Yabe, Hirooki
Publicado 2019

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report

por Horikoshi, Sho, Miura, Itaru, Kunii, Yasuto, Asano, Satoko, Kanno-Nozaki, Keiko, Mashiko, Hirobumi, Yabe, Hirooki
Publicado 2017

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder

por Ichinose, Mizue, Miura, Itaru, Horikoshi, Sho, Yamamoto, Shinnosuke, Kanno-Nozaki, Keiko, Watanabe, Kenya, Yabe, Hirooki
Publicado 2021

PM446. The relationship between MMN and COMT Val108/158Met genotype in schizophrenia

por Horikoshi, Sho, Shiga, Tetsuya, Hoshino, Hiroshi, Ochiai, Haruka, Kanno, Keiko-Nozaki, Kanno, Kazuko, Kaneko, Haruka, Miura, Itaru, Yabe, Hirooki
Publicado 2016

PM516. Association of DNA Methylation of Taq1A in the DRD2 with Response to Aripiprazole in acute schizophrenia

por Miura, Itaru, Bundo, Miki, Hino, Mizuki, Horikoshi, Sho, Hoshino, Hiroshi, Iwamoto, Kazuya, Kaneko, Haruka, Kanno-Nozaki, Keiko, Kunii, Yasuto, Matsumoto, Junya, Yabe, Hirooki
Publicado 2016